LLY

Last

$1,280.90

Trade XYZ · xyz:LLY

24h Chg

+0.13%

24h Vol

$655.7K

Venue 1 / 1

$4.8M

perp notional

01 /

Markets on Hyperliquid (1)

	Venue	Type	Last	24h Chg	24h Vol	Trade
	Trade XYZ xyz:LLY	HIP-3	1,280.90	+0.13%	$655.7K	Trade

02 /

Outcome Markets on Hyperliquid (2)

Resolution times below are countdown to settlement

Outcome trading on Hyperliquid is unavailable in some jurisdictions.

LLY above 1,450 at Oct 30, 13:35 UTC?
Stocks
Above/below · Trade XYZ Events
3d 7h · Vol $0.00 · OI $0.00
Ref. xyz:LLY mark 1,280.60 · -11.7% vs threshold
Reference perp price, not the settlement price. Settles on: 300s TWAP · 1-minute candle
Trade↗
- Yes49.5%
- No50.5%
LLY above 1,180 at Oct 30, 13:35 UTC?
Stocks
Above/below · Trade XYZ Events
3d 7h · Vol $0.00 · OI $0.00
Ref. xyz:LLY mark 1,280.60 · +8.5% vs threshold
Reference perp price, not the settlement price. Settles on: 300s TWAP · 1-minute candle
Trade↗
- YesNo quote
- NoNo quote

03 /

About LLY

Large-cap biopharma exposure driven by diabetes, obesity, and specialty-drug leadership.

Stocks

LLY tracks the value of shares in Eli Lilly and Company, a global pharmaceutical firm focused on developing treatments for diabetes, obesity, oncology, and immunology, with recent growth driven by demand for GLP-1 based therapies. The stock is widely used as a large-cap biopharma benchmark tied to innovation in metabolic disease and specialty therapeutics.

Tracks: NYSE:LLY ↗

04 /

Price Action

LLY on XYZ